Incipiam Pharma

Incipiam means ”I will begin” and that is where we believe we are – at the forefront of a paradigm shift in metabolic disease treatment. Most treatment options currently in development for metabolic disease focus on reduction of energy intake. While this is important, we see a new era of weight loss therapeutics emerging, where reduction in energy intake is insufficient to advance both the understanding of metabolic disease but also to drive development of novel treatments. At Incipiam Pharma, we're pioneering the next wave of weight loss therapeutics, targeting energy expenditure to revolutionize treatment for those living with obesity and diabetes.